The purpose of this study is to assess the efficacy of neuromodulation for treatment of chronic constipation and fecal incontinence in pediatric patients and to evaluate the differences between the invasive vs. non-invasive approach.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change of episodes of abdominal pain
Timeframe: Baseline and 12 and 24 weeks after start of therapy
Change of episodes of fecal incontinence
Timeframe: Baseline and 12 and 24 weeks after start of therapy
Change of defecation frequency
Timeframe: Baseline and 12 and 24 weeks after start of therapy
Change of defecation consistency
Timeframe: Baseline and 12 and 24 weeks after start of therapy